Bromide Source for Autism Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for autism spectrum disorder (ASD) lack effective alternatives, particularly for social deficit and anxiety symptoms, with existing medications often having side effects and limited therapeutic windows.
Innovation Solution
Administration of a source of bromide, such as potassium or sodium bromide, which improves cognitive flexibility and alleviates social deficit and anxiety associated with ASD, potentially offering a broader therapeutic window and chronic/transient treatment options.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing medications are used to treat ASD symptoms, then specific symptoms such as anxiety and behavioral problems can be addressed, but the treatments have side effects and limited therapeutic windows
Solution Approach 1:
The patent changes the chemical parameter by substituting conventional medications with bromide compounds, which have different pharmacological properties. Bromide provides a broader therapeutic window and different side effect profile compared to existing ASD medications, thereby resolving the contradiction between treatment effectiveness and harmful side effects
Solution Approach 2:
The patent employs bromide compounds that can be administered in straightforward dosage forms without requiring complex delivery systems or monitoring infrastructure. This simplifies the treatment approach while maintaining efficacy, reducing the complexity burden associated with managing medications for ASD
2Adaptability or versatility
If conventional treatments are administered, then some symptoms can be managed, but there is no cure and treatment options are limited
Solution Approach 1:
The patent applies bromide compounds that can address multiple ASD-related symptoms simultaneously, including anxiety, repetitive behaviors, and social deficits. This multi-functional approach expands treatment versatility while providing a unified therapeutic strategy that manages various symptoms without requiring multiple specialized medications
3Reliability
If bromide is used to treat ASD, then social deficit and anxiety symptoms improve with broader therapeutic window, but the mechanism differs from conventional anti-epileptic use
Solution Approach 1:
The patent utilizes bromide's ability to modulate GABAergic neurotransmission, which provides a broader therapeutic window for ASD treatment compared to conventional medications. By leveraging bromide's neurochemical effects rather than its traditional anti-epileptic mechanism, the treatment achieves improved reliability with expanded therapeutic margins
Data Source
AI summary
The present invention relates to a novel pharmaceutical use of bromide, i.e. the treatment of autism spectral disorder (ASD).